Blood plasma-based drug against COVID-19 successfully passes clinical trials
… received a permanent certification by the Russian Health Ministry
… confirmed its efficacy, safety and the ability to neutralize the coronavirus
… on the basis of the blood plasma of individuals who had been infected with COVID-19
… contains antibodies to the virus
… prevents the disease from taking on a more severe form and helps fight the infection
… double-blind placebo-controlled …the risk of developing a more severe form of the disease decreased
… most effective at the early stages of the disease
… In 70% of cases, therapy prevented the development of such complications
… as a cytokine storm, kidney failure, thromboembolic complications
… the development of acute respiratory distress syndrome, extensive lung damage or worsened clinical symptoms
… The first preparation of the specific anti-COVID immunoglobulin worldwide has successfully passed … proving its safety and efficacy